Frank Claessens

Frank Claessens

Katholieke Universiteit Leuven

H-index: 74

Europe-Belgium

About Frank Claessens

Frank Claessens, With an exceptional h-index of 74 and a recent h-index of 48 (since 2020), a distinguished researcher at Katholieke Universiteit Leuven, specializes in the field of androgen action, prostate cancer, musculoskeletal system, genomics and epigenetics, molecular biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

Structural mechanism underlying variations in DNA binding by the androgen receptor

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

Rational evolution for altering the ligand preference of estrogen receptor alpha

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium

Molecular effects of neo-adjuvant hormone therapy for locally advanced prostate cancer: An ancillary study of the ARNEO phase 2 trial

Androgen deprivation therapy-resistant club cells are linked to myeloid cell-driven immunosuppression in the prostate tumor microenvironment

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

Frank Claessens Information

University

Katholieke Universiteit Leuven

Position

___

Citations(all)

39250

Citations(since 2020)

26061

Cited By

23103

hIndex(all)

74

hIndex(since 2020)

48

i10Index(all)

190

i10Index(since 2020)

140

Email

University Profile Page

Katholieke Universiteit Leuven

Frank Claessens Skills & Research Interests

androgen action

prostate cancer

musculoskeletal system

genomics and epigenetics

molecular biology

Top articles of Frank Claessens

Title

Journal

Author(s)

Publication Date

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

EBioMedicine

James Yarmolinsky

Jamie W Robinson

Daniela Mariosa

Ville Karhunen

Jian Huang

...

2024/2/1

Structural mechanism underlying variations in DNA binding by the androgen receptor

The Journal of Steroid Biochemistry and Molecular Biology

Xiao Yin Lee

Wout Van Eynde

Christine Helsen

Hanne Willems

Kaat Peperstraete

...

2024/4/10

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

British Journal of Cancer

Eleanor L Watts

Tomas I Gonzales

Tessa Strain

Pedro F Saint-Maurice

D Timothy Bishop

...

2024/1/31

Rational evolution for altering the ligand preference of estrogen receptor alpha

Protein Science

Roy Eerlings

Purvi Gupta

Xiao Yin Lee

Tien Nguyen

Sarah El Kharraz

...

2024/4

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium

Journal of Translational Medicine

Sherif Mehralivand

Christian Thomas

Martin Puhr

Frank Claessens

Arjanneke F van de Merbel

...

2024/1/18

Molecular effects of neo-adjuvant hormone therapy for locally advanced prostate cancer: An ancillary study of the ARNEO phase 2 trial

Cancer Research

Mazlina Ismail

Wout Devlies

Marina Parry

Gaetan Devos

Stefanie Friedrich

...

2024/3/22

Androgen deprivation therapy-resistant club cells are linked to myeloid cell-driven immunosuppression in the prostate tumor microenvironment

bioRxiv

Antti Kiviaho

Sini K Eerola

Heini ML Kallio

Maria K Andersen

Xander Spotbeen

...

2024

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

The Lancet

Nowell H Phelps

Rosie K Singleton

Bin Zhou

Rachel A Heap

Anu Mishra

...

2024/2/29

Discovery of a novel androgen receptor antagonist, MEL-6, with stereoselective activity and optimization of its metabolic stability

Journal of Medicinal Chemistry

Weitao Fu

Minkui Zhang

Jianing Liao

Qing Tang

Yixuan Lei

...

2021/11/23

A multivalent peptoid conjugate that inhibits therapy-resistant prostate cancer cell proliferation by modulating androgen receptor transcriptional activity

Cancer Research

Justine Habault

Jeffrey A Schneider

Susan Ha

Rachel Ruoff

Joseph Puccini

...

2023/4/4

Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients

Alexander Giesen

Loïc Baekelandt

Wout Devlies

Gaëtan Devos

Herlinde Dumez

...

2023

# 4184 MALE CHRONIC KIDNEY DISEASE IS A STATE OF PREMATURE TESTICULAR AGING

Nephrology Dialysis Transplantation

Karel David

Nick Narinx

Jetty De Loor

Leen Antonio

Dirk Vanderschueren

...

2023/6

Decoding the Significance of Peroxisomes as Redox Modulators in Prostate Cancer Cells

Mohamed Hussein

Celien Lismont

Claudio Figueiredo Costa

Hongli Li

Frank Claessens

...

2023/9/4

Androgen Deprivation Modulates the Adrenocortical Stress Response

Endocrine Abstracts

V Sommers

M Gentenaar

E Viho

C Helsen

V Dubois

...

2023/11/17

Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer

Protein Science

Christine Helsen

Maria Santa Rocca

Tien T Nguyen

Roy Eerlings

Xiao Yin Lee

...

2023/4

Crosstalk between androgen receptor and WNT/β-catenin signaling causes sex-specific adrenocortical hyperplasia in mice

Disease Models & Mechanisms

Rodanthi Lyraki

Anaëlle Grabek

Amélie Tison

Lahiru Chamara Weerasinghe Arachchige

Mirko Peitzsch

...

2023/6/1

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

Diabetologia

James Yarmolinsky

Emmanouil Bouras

Andrei Constantinescu

Kimberley Burrows

Caroline J Bull

...

2023/8

Changes in bone and mineral homeostasis after short-term androgen deprivation therapy with or without androgen receptor signalling inhibitor–substudy of a single-centre, double …

Ebiomedicine

Karel David

Gaëtan Devos

Nick Narinx

Leen Antonio

Wout Devlies

...

2023/11/1

Androgen therapy does not prevent bone loss and arterial calcifications in male rats with chronic kidney disease

Journal of Endocrinology

Karel David

Vanessa Dubois

Anja Verhulst

Vera Sommers

Dieter Schollaert

...

2023/6/1

Diminishing benefits of urban living for growth and development of school-aged children and adolescents in the 21st century

Anu Mishra

Bin Zhou

Andrea Rodriguez-Martinez

Honor Bixby

Rosie Singleton

...

2023/3/29

See List of Professors in Frank Claessens University(Katholieke Universiteit Leuven)

Frank Claessens FAQs

What is Frank Claessens's h-index at Katholieke Universiteit Leuven?

The h-index of Frank Claessens has been 48 since 2020 and 74 in total.

What are Frank Claessens's top articles?

The articles with the titles of

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

Structural mechanism underlying variations in DNA binding by the androgen receptor

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

Rational evolution for altering the ligand preference of estrogen receptor alpha

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium

Molecular effects of neo-adjuvant hormone therapy for locally advanced prostate cancer: An ancillary study of the ARNEO phase 2 trial

Androgen deprivation therapy-resistant club cells are linked to myeloid cell-driven immunosuppression in the prostate tumor microenvironment

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

...

are the top articles of Frank Claessens at Katholieke Universiteit Leuven.

What are Frank Claessens's research interests?

The research interests of Frank Claessens are: androgen action, prostate cancer, musculoskeletal system, genomics and epigenetics, molecular biology

What is Frank Claessens's total number of citations?

Frank Claessens has 39,250 citations in total.

What are the co-authors of Frank Claessens?

The co-authors of Frank Claessens are Mike Lean (MEJ Lean), Steven Joniau, Pendleton N, Dieter Deforce, Stein Aerts, louise deldicque.

Co-Authors

H-index: 124
Mike Lean (MEJ Lean)

Mike Lean (MEJ Lean)

University of Glasgow

H-index: 79
Steven Joniau

Steven Joniau

Katholieke Universiteit Leuven

H-index: 74
Pendleton N

Pendleton N

Manchester University

H-index: 67
Dieter Deforce

Dieter Deforce

Universiteit Gent

H-index: 57
Stein Aerts

Stein Aerts

Katholieke Universiteit Leuven

H-index: 49
louise deldicque

louise deldicque

Université Catholique de Louvain

academic-engine